Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluciclovine PET/CT in bone-metastatic prostate cancer
NCT03707184Phase 2Completed
- Sponsor
- University of Utah
- Start
- Oct 2018
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by University of Utah. Started Oct 2018; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03707184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707184.